Status:
COMPLETED
Effect of Biphasic Insulin Aspart 30 on Blood Glucose Control in Subjects With Type 2 Diabetes
Lead Sponsor:
Novo Nordisk A/S
Conditions:
Diabetes
Diabetes Mellitus, Type 2
Eligibility:
All Genders
40-70 years
Phase:
PHASE3
Brief Summary
This trial was conducted in Russian Federation. This trial aimed for a comparison of the effect on glycemic control in subjects with type 2 diabetes of three different treatment regimens: biphasic ins...
Eligibility Criteria
Inclusion
- Type 2 diabetes, currently treated with one or more oral hypoglycemic agent
- HbA1c: At least 8.0%
Exclusion
- Impaired hepatic, renal or cardiac function
Key Trial Info
Start Date :
November 1 2003
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2004
Estimated Enrollment :
307 Patients enrolled
Trial Details
Trial ID
NCT00280046
Start Date
November 1 2003
End Date
July 1 2004
Last Update
January 6 2017
Active Locations (11)
Enter a location and click search to find clinical trials sorted by distance.
1
Novo Nordisk Investigational Site
Arkhangelsk, Russia, 163045
2
Novo Nordisk Investigational Site
Belgorod, Russia, 308007
3
Novo Nordisk Investigational Site
Kazan', Russia, 420064
4
Novo Nordisk Investigational Site
Khabarovsk, Russia, 680067